Viridian Therapeutics, Inc./DE Cash
Viridian Therapeutics, Inc./DE (VRDN) had Cash of $10.45 million as of 2015-06-30, per its 10-Q filed 2015-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2015-08-14
- 2015-06-30: Cash $10.45M.
- 2015-03-31: Cash $13.27M.
- 2014-12-31: Cash $5.12M.
- 2014-06-30: Cash $7.70M.
| Period end | Cash |
|---|---|
| 2015-06-30 | $10.45M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $13.27M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $5.12M 10-Q · filed 2015-08-14 |
| 2014-06-30 | $7.70M 10-Q · filed 2015-08-14 |
| 2014-03-31 | $105.00K 10-Q · filed 2015-05-15 |
| 2013-12-31 | $209.00K 10-Q · filed 2015-08-14 |
| 2012-12-31 | $112.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |